Consist of Infection and Immune-Related Diseases expertsInnovative new drugs development company
Develops Immunosuppressants and Antibiotics against Super Bacteria to combat SepsisA global biopharmaceutical company
Contributing to the Health of Human-beingsWith HLB SCIENCE
DD-S052P is an innovative candidate that exterminates germs and eliminates endotoxins.
Antibiotics that treat sepsis are designed to exterminates the causative pathogens, however, the removal of endotoxins released during the apoptosis of pathogens is overlooked. Especially, the cytokine storm phenomenon, that exacerbate the morbidity of sepsis by causing necrosis in several tissues.
Synergistic effect by co-administration with existing antibiotics (easier access to clinical trials)
committed to protecting the health
well-being of more people
with the best experts.
DD-A279 is a new treatment to cure Alzheimer's Diseases by controlling LPS and Gram-negative bacteria.
DD-A514 is a quick and accurate Diagnosis kit for Alzheimer's diseases.
Alzheimer's diseases cannot be cured in current time. However, through out the research, we found out that LPS and Gram-negative bacteria affects to generate Alzheimer's diseases. Moreover, it is difficult to diagnose Alzheimer's diseases because of expansive and difficult diagnose kit.
Treatment for Alzheimer's diseases
Diagnosis kit for Alzheimer's diseases
6F, 66, Achasan-ro, Seongdong-gu, Seoul, Republic of Korea
810, Dongtan M Tower 8th floor, Dongtancheomdansaneop 1-ro, Hwaseong-si, Gyeonggi-do